THE COOPER COMPANIES, INC. The Cooper Companies, Inc. Share Price Börse Stuttgart
Equities
CP60
US2166485019
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.6 EUR | -0.52% |
|
-0.23% | +0.41% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.89B 3.63B 306B | Sales 2025 * | 4.15B 3.87B 327B | Capitalization | 18.61B 17.39B 1,468B |
|---|---|---|---|---|---|
| Net income 2024 * | 452M 422M 35.64B | Net income 2025 * | 595M 556M 46.92B | EV / Sales 2024 * | 5.38 x |
| Net Debt 2024 * | 2.28B 2.13B 180B | Net Debt 2025 * | 1.76B 1.65B 139B | EV / Sales 2025 * | 4.91 x |
| P/E ratio 2024 * |
42.9
x | P/E ratio 2025 * |
30.8
x | Employees | - |
| Yield 2024 * |
0.06% | Yield 2025 * |
0.04% | Free-Float | 91.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Cooper Companies, Inc.
More recommendations
More press releases
More news
| 1 week | -0.23% | ||
| Current month | +0.46% | ||
| 1 month | -0.80% | ||
| 3 months | -6.83% | ||
| 6 months | +4.49% | ||
| Current year | +0.41% |
1 week
86.00
88.35
1 month
82.6089.50
3 years
63.7596.73
5 years
55.5096.73
10 years
23.9196.73
| Managers | Title | Age | Since |
|---|---|---|---|
Albert White
CEO | Chief Executive Officer | 54 | 31/03/06 |
Robert Weiss
CHM | Chairman | 77 | 31/12/76 |
Brian Andrews
DFI | Director of Finance/CFO | 45 | 31/03/06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Teresa Madden
BRD | Director/Board Member | 67 | 30/11/20 |
Lawrence Kurzius
BRD | Director/Board Member | 66 | 11-30 |
William Kozy
BRD | Director/Board Member | 72 | 31/03/16 |
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 86.6 | -0.52% |
| 13/06/24 | 87.05 | +1.22% |
| 12/06/24 | 86 | -0.46% |
| 11/06/24 | 86.4 | -0.69% |
| 10/06/24 | 87 | +0.23% |
Delayed Quote Börse Stuttgart, June 14, 2024 at 09:05 am
More quotes
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
28/08/2024
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
93.47
USD
Average target price
108.2
USD
Spread / Average Target
+15.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.68% | 97.93B | |
| -22.59% | 2.16B | |
| +14.96% | 1.93B | |
| +17.53% | 1.12B | |
| -9.75% | 654M | |
| -44.15% | 647M | |
| +66.86% | 641M | |
| -46.30% | 614M | |
| +23.50% | 521M |
- Stock Market
- Equities
- COO Stock
- CP60 Stock
